As bstract. Prolonged exposure to glucocorticoids in pharmacologic amounts results in muscle wasting, but whether changes in plasma cortisol within the physiologic range affect amino acid and protein metabolism in man has not been determined. To determine whether a physiologic increase in plasma cortisol increases proteolysis and the de novo synthesis ofalanine, seven normal subjects were studied on two occasions during an 8-h infusion ofeither hydrocortisone sodium succinate (2 1g 
Introduction
Prolonged administration of pharmacologic amounts of glucocorticoids in man causes muscle wasting (1) . Both stimulation of proteolysis and inhibition of protein synthesis have been implicated in this loss of body protein. The proteolytic effect ofpharmacologic amounts ofglucocorticoids on skeletal muscle is evidenced by increases in (a) efflux of amino acids from incubated rat muscle (2-4); (b) plasma amino acid concentrations in eviscerated animal preparations (5, 6) ; (c) plasma urea nitrogen (2); (d) muscle dipeptidase activity (7) ; and (e) 3-methylhistidine excretion (8) . In contrast, no significant increase in protein degradation was observed in rat muscle following several days of high dose in vivo corticosterone exposure (9) (10) (11) . Inhibition of protein synthesis also has been invoked to explain the protein catabolic state induced by steroids on the basis of decreased incorporation of amino acids into rat muscle following glucocorticoid treatment (9) (10) (11) (12) .
In man, increases in urinary nitrogen excretion and plasma concentrations ofalanine and glutamine are observed only after 24-48 h of exposure to pharmacologic doses of glucocorticosteroids (13, 14) . These data suggest that several days may be required before evidence of a glucocorticoid effect on amino acid metabolism can be seen in man. Whether short-term changes in plasma cortisol concentration within the physiologic range affect protein metabolism in man has not been determined. Infusion of cortisol to achieve high physiologic concentrations increases the plasma concentrations of phenylalanine and the branched-chain amino acids, leucine, isoleucine, and valine (15). An increase in the plasma concentration of these essential amino acids in the postabsorptive state could result from either increased proteolysis or decreased utilization (oxidation and/or protein synthesis). Since the branched-chain amino acids are an important nitrogen source for synthesis of the potential gluconeogenic substrate alanine in vivo (16) (17) (18) , cortisol stimulation of proteolysis could increase alanine availability via de novo synthesis, as well as directly from protein. The present studies were designed to determine if increases of plasma cortisol within the physiologic range could increase the rate ofappearance ofleucine, an indicator of whole body proteolysis, and, if so, to determine the effect of increased availability of leucine on the de novo synthesis of alanine.
Methods
Subjects. Informed consent was obtained from seven healthy adult volunteers between the ages of 23 and 38 yr. All were within 10% of ideal body weight (Metropolitan Life Insurance Table) and none had a family history of diabetes mellitus. The subjects had consumed a weight-maintaining diet containing at least 200 g of carbohydrate for a minimum of 3 d before study. All volunteers were admitted to the Clinical Study Unit on the afternoon before study and were provided a 600-cal meal at 1800 h. On the evening before study, an 18-gauge plastic catheter was inserted into a forearm vein for isotope infusion.
Experimental design. Each subject was studied on two occasions separated by at least 2 wk, once during infusion of hydrocortisone sodium succinate (2 pg/kg. min) beginning at 0 time, and on a second occasion during saline infusion. At -8 h, a constant infusion of L- ['5NJleucine was begun at a rate (0.14 Amol/kg * min) to enrich the circulating plasma pool of leucine to '-5 mol% and was continued to the end of the study. Isotopic equilibration of '5N into the alanine pool has been demonstrated to occur in this period of time (18 (3, 800 dpm/kg. min) was begun at -4 h and continued throughout the study. At zero time (I 100 h), an infusion of either saline or cortisol (2 Mg/kg. min) was begun and continued throughout the study period (hour 8).
Arterialized venous blood was obtained from a 19-gauge scalp vein needle placed retrograde in the contralateral hand vein (19, 20) . Blood samples were obtained at -2, -1.5, -1, -0.5, 0, 0.5, and 1 h, and subsequently at 1-h intervals through hour 8.
Approximately 17 ml of blood were drawn at each sampling and aliquoted in the following fashion: 5 ml were added to a tube containing EDTA and benzamadine for assay of glucagon, insulin, C-peptide, and cortisol; 10 ml were added to a tube containing sodium heparin for amino acid and substrate analysis; and 2 ml were added to a tube containing sodium fluoride for determination of glucose and glucose specific activity. All (33) , modified for nonsteadystate conditions (34). Apparent rates of appearance (Ra) and disappearance (Rd) for alanine and leucine were determined using Steele's equations for nonsteady-state conditions adapted for stable isotopic tracers (18, 35) . The assumptions and equations for estimating Ra, Rd, and nitrogen exchange used have been previously described (16) (17) (18) . Apparent rates of leucine appearance and disappearance calculated from [2H3J1eucine were used to determine leucine carbon (C) kinetics, since this tracer provides rates of leucine flux similar to those obtained with (36) , and [1_'3C]leucine (37) . Rates of appearance of [I5Njalanine, percentage of alanine nitrogen derived from leucine, and the percentage and rate of leucine nitrogen transfer to alanine were calculated using standard product precursor relationships (16) (17) (18) .
Results
Plasma hormone concentrations. During the infusion of hydrocortisone, plasma cortisol concentrations increased (P < 0.00 1) from 10±1 sg/dl to 42±4 Ag/dI by hour 3, and subsequently remained nearly constant. During infusion of saline, plasma cortisol concentrations decreased from 14±2 jsg/dl to 9.5±2 ,g/ dl (P < 0.05) at hour 8 ( Fig. 1 ). Plasma concentrations ofinsulin (9.0±0.2 ,U/ml and 9.1±0.2 gU/ml), C-peptide (1.7±0.1 and 1.9±0.1 Ag/ml), and glucagon (287±5 and 298±12 pg/ml) were not significantly different before infusion of saline or cortisol and did not change subsequently (Fig. 1) .
Effects of cortisol on leucine metabolism. Plasma leucine 1. Abbreviations used in this paper: GC/MS, gas chromatography-mass spectrometry; KIC, a-ketoisocaproate; Ra, rate(s) of appearance; Rd, rate(s) of disappearance. concentration increased 70% (120±1 to 203±21 ,uM, P < 0.01) during cortisol, but only 30% (118±8 to 154±4 IM, P < 0.05) during saline infusion. Although base-line leucine values were not different on the two study days, plasma leucine concentration was higher (P < 0.05) by hour 3 of the cortisol when compared with that ofthe saline infusion and remained so for the duration of study (Fig. 2) . During cortisol infusion, the rate of leucine carbon (C) appearance increased (P < 0.01) by 23% from 1.47±0.08 to 1.81±0.08 ,umol/kg-min; whereas during saline infusion leucine C Ra did not change (1.50±0.08 vs. 1.57±0.09 sAmol/kg-min) (Fig. 2) . The Rd of leucine carbon also increased (P < 0.01) by 24% from 1.47±0.05 to 1.83±0.09 gmol/kg -min during the cortisol infusion but remained unchanged during the saline infusion (1.50±0.08 vs. 1.55±0.05 gmol/kg min) (Fig. 2) .
The Ra of leucine nitrogen (N) increased (P < 0.01) by nearly 50% from 2.35±0.12 to 3.46±0. 24 ,mol/kg-min during the cortisol infusion, but increased by only 17% (P < 0.05) during the saline infusion (2.43±0.17 to 2.85±0.15 Mmol/ kg. min) (Fig. 3) . The increase in leucine N Ra during cortisol administration was greater (P < 0.01) than that observed during saline infusion. The Rd of leucine N increased (P < 0.01) by 50% during cortisol infusion (2.35±0.12 to 3.48±0.25 umol/ kg. min) but by only 17% (P < 0.05) during the saline infusion (2.43±0.17 to 2.84±0.15 gmol/kg-min) (Fig. 3) . By hour 8, the plasma alanine had decreased (P < 0.01) by 64±17 AM. In contrast, during cortisol infusion, plasma alanine did not significantly change (A -9±11 AM at hour 8, cf basal values). The change in plasma alanine concentration between the two study days was different (P < 0.05) between hour 7 and 8 (Fig. 4) . Alanine Ra and Rd decreased during the saline infusion but were not significantly different from basal values. In contrast, during cortisol infusion, alanine Ra and Rd were increased (P < 0.05) above basal values by hour 7; and, the Ra and Rd of alanine between the infusion days were different (P < 0.05) from hour 5 to the end of the study (Fig. 4) . (Fig. 4) . derived from leucine N was similar on the two study days ( 15±2 vs. 16±1%, respectively). Because of the differences in basal values, the data are expressed as change from base line to facilitate comparison between the saline and cortisol studies (Fig. 5) . During cortisol infusion, the rate of leucine N transferred to alanine N was increased (P < 0.05) above the basal value during the last 4 h of study. The increase was greater over the last 3 h of study (P < 0.02) than that observed during saline infusion, which did not change over the course of the study. The percentage of leucine N transferred to alanine increased (P < 0.05) at hour 7 and 8 during only the cortisol infusion, and was significantly different from that of the saline infusion at hour 8 (Fig. 5 ). An increase (P < 0.02) in the percentage of alanine nitrogen derived from leucine was observed over the last 3 h during both the cortisol and saline infusions.
Effects of cortisol infusion on the plasma concentration of other amino acids. The summed total of all the plasma amino acid concentrations was increased (P < 0.05) during the cortisol infusion but not during saline infusion (Table I) . This is primarily attributable to the increase in the plasma concentrations of valine, leucine, isoleucine, tyrosine, phenylalanine, and histidine during cortisol but not during saline infusion.
Glucose range increases the plasma leucine concentration as a result of a greater stimulation ofthe Ra than Rd of leucine. The increase in the leucine Ra occurred in the absence of changes in plasma insulin, C-peptide, and glucagon. Since the only source of this essential amino acid in the postabsorptive state is tissue protein, we conclude that an increase ofplasma cortisol within the physiologic range stimulates whole body proteolysis. This conclusion is consistent with the observed increased urinary nitrogen excretion (14) and with elevations in the plasma concentrations of other amino acids in this and previous studies (13) (14) (15) . The tissue(s) in which this increased protein breakdown occurs cannot be determined from our studies. Pharmacologic doses of glucocorticosteroids result in increased 3-methylhistidine excretion (8) , suggesting that proteolysis in skeletal muscle may be enhanced. Whether a physiologic increase in plasma glucocorticoid concentrations has similar effects is not known. However, cortisol may affect proteolysis to a greater extent in tissues with more rapid protein turnover (e.g., liver, gut, skin, bone marrow) than in skeletal muscle (38) . Due to the relatively long period of isotope infusion in our study, labeled leucine may have been incorporated into and released from protein (39). This potential recycling of label would centrations did not change during cortisol infusion but decreased during saline infusion (P < 0.05) (Table II) . Plasma FFA, f3-hydroxybutyrate, and acetoacetate concentrations increased similarly on both study days (Table II) . As demonstrated here and in previous studies in man and dogs (16) (17) (18) 40) , the flux of leucine nitrogen, as estimated from the ["N]ileucine data, exceeds that of leucine carbon. Since
[12H3]1eucine is probably transaminated to KIC and back to leucine without loss of label whereas the '5N would be lost to a large nitrogen pool, these results are consistent with a rate of leucine transamination that is higher than irreversible loss of leucine carbon. Whether this high rate of transamination reflects "futile" transamination of leucine in a single tissue or its transport as the a-ketoacid from peripheral tissues to liver under these conditions remains unknown; however, recent studies in the rats (41) and dogs (42) lend support to the latter hypothesis. If the ratio of leucine N to leucine C flux is a reflection of the activity of the proposed leucine-KIC shuttle, then cortisol has no effect on the relative activity of this shuttle since the changes in the ratio ofthe leucine N/leucine C flux were identical during cortisol and saline infusions (1.47-1.80 with saline; 1.47-1.89 with cortisol).
In the postabsorptive state, alanine appearance into the plasma space represents the sum of alanine release from protein (proteolysis) and production from de novo synthesis (16) (17) (18) 43) . Assuming alanine and leucine content of body protein are 6 and 8%, respectively (44) , the rate of alanine release from protein can be calculated from leucine C appearance rates (16) (17) (18) 43) . The calculated rate of alanine release from protein during cortisol infusion increased 23% (from 1.63 to 2.00 ,umol/ kg min), whereas during saline infusion, it increased by only 5% (from 1.66 to 1.74 ,umol/kg. min). The total alanine Ra increased from 4.56 to 6.29 gmol/kg-min during cortisol infusion; therefore, the rate of alanine synthesis (alanine Ra -alanine released from protein) increased by 46% from 2.93 to 4.29 ,mol/kg * min. In contrast, alanine synthesis during saline infusion did not increase (from 4.25 to 3.57 ,mol/kg * min). The fact that the rate and percentage of leucine N going to alanine significantly increased only during cortisol infusion is further evidence of a cortisol-mediated stimulation of de novo alanine synthesis. Because the increases in the percentage of alanine N derived from leucine were not different on the two study days, we conclude that cortisol did not selectively affect the transfer ofN from the branched-chain amino acids to alanine. It is of interest to note that the difference in basal alanine flux on the two study days is attributable to differences in the rates ofalanine synthesis, rather than ofproteolysis, since basal leucine carbon rates of appearance were similar on the two study days. This interpretation is supported by our observation of higher basal rates and percentages of leucine N transfer to alanine during the base-line period of study on the saline infusion day as compared with the day of cortisol infusion.
During cortisol infusion alanine Ra increased. However, alanine concentration did not change because its Rd increased to the same extent. In contrast, the plasma alanine concentration during saline infusion decreased. This was presumably due to a decrease in alanine Ra, since alanine Rd did not increase. It should be noted that the changes in the plasma concentration of lactate, a potential carbon source for alanine synthesis, paralleled those ofalanine on the two study days. However, plasma concentrations of pyruvate, the immediate precursor to alanine synthesis, did not follow this pattern. During cortisol infusion, the sustained plasma lactate and alanine concentrations and the increase in alanine turnover were associated with higher glucose concentrations than observed on the control day. Whether this higher plasma glucose concentration was the result of increased availability of these gluconeogenic substrates cannot be determined from the present studies, since a carbon-labeled alanine was not used.
In summary, the present studies demonstrate that an increase of cortisol within the physiologic range stimulates proteolysis independently of changes in plasma insulin and glucagon. The increase in alanine turnover observed during cortisol infusion was not only the result of enhanced proteolysis but of an even greater increase in alanine synthesis. The latter is consistent with a cortisol-mediated stimulation of the postulated glucosealanine cycle (45) . The increased availability of potential gluconeogenic substrates (alanine and possibly lactate and pyruvate) may contribute to the changes in carbohydrate metabolism observed during stress and other hypercortisolemic states.
